Guangzhou Baxter Qiaoguang Healthcare Co., Ltd. (Baxter Qiaoguang) is a joint venture between Baxter (China) Investment Co., Ltd. and Guangzhou Baiyunshan Pharmaceutical Co., Ltd., a subsidiary of GPHL. The joint venture produces and develops parenteral nutrition products and is committed to becoming the leading company in parenteral nutrition industry in China.

Baxter Qiaoguang, a dedicated manufacturer of parenteral nutrition products, is devoted to providing patients with high-quality products and services and raising awareness of parenteral nutrition. Its major products include:

- Medium and Long Chain Fat Emulsion Injection C8-24) (侨光卡路®)

- Long Chain Fat Emulsion Injection (OO) (ClinOleic®)

- Long Chain Fat Emulsion Injection C14-24 (卡里®)

- Lipid emulsion 10% / 15 L-amino acids / glucose 20% (Clinomel®)

- Multivitamins for Infusion (12) (Cernevit®)

- Compound Amino Acid Injection (15AA) (肝安®)

Honors

2012  Enterprise with Occupational Safety and Health Management System

2014  “Company with A-Line Credit in Chemicals and Pharmaceuticals Industry” issued by China Pharmaceutical Industry Association

(Translator: Michelle Wang; Editors: Simon Haywood, Olivia Yang, Monica Liu)